Sangamo Therapeutics Inc.

06/08/2024 | Press release | Archived content

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases